Loading
Life sciences · Journal article
Ayushdhara · November 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Sthaulya is an important Santarpanajanya Vyadhi described in Ayurveda, characterized by excessive accumulation of Meda with involvement of Kapha, Agni and Medovaha Srotas. Obesity is a major public-health concern and is frequently associated with metabolic abnormalities, particularly dyslipidaemia. Globally, approximately 16% of adults were living with obesity in 2022. The present study evaluated and compared the efficacy of Dashanga Guggulu and Navaka Guggulu in Sthaulya with special reference to hyperlipidaemia. An open-label, randomized comparative clinical study was conducted among 50 subjects aged 18–60 years. Subjects were allocated into two groups of 25 each; 5 subjects from each group did not complete the study, and 40 subjects were included in the final analysis. Group A received Dashanga Guggulu and Group B received Navaka Guggulu, 1000mg twice daily after food with lukewarm water for 40 days. Assessment included subjective symptoms, anthropometric parameters and lipid profile. Both groups showed statistically significant improvement in the assessed parameters. Mean body weight decreased from 78.70 to 73.80kg in Group A and from 77.20 to 71.70kg in Group B. Total cholesterol decreased from 277.50 to 213.60mg/dL and from 279.50 to 211.10mg/dL, respectively. Overall improvement was 55.07% in Group A and 63.61% in Group B. Navaka Guggulu demonstrated a comparatively better overall therapeutic response.